Image: StatnewsWe're reading about drug pricing deals, a new cancer therapy approval, and more
• The White House is finalizing drug pricing agreements with pharmaceutical companies Bayer, Takeda, and CSL Behring. • These deals are part of a broader initiative by the U.S. government to secure more affordable medication costs through direct negotiations with drugmakers. • The news coincides with the approval of a new cancer therapy, highlighting a period of significant regulatory and financial shifts in the pharma industry.
statnews.com



